Αρχική World News Disparities in Cancer Care Between Citizens and Refugees in Lebanon

Disparities in Cancer Care Between Citizens and Refugees in Lebanon

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with cancer in their region. Mona Hassan, MD, graduated from Beirut Arab University, Faculty of Medicine in Beirut, Lebanon. She is currently a PGY3 internal medicine resident at the American University of Beirut Medical Center. Dr. Hassan aims to continue her fellowship in hematology-oncology with a focus on bone marrow transplantation and CAR T-cell therapy. Dr. Hassan has no relevant relationships to disclose. You can follow Dr. Hassan on Twitter.

Why I care for people with cancer

I went into internal medicine residency knowing that I wanted hematology-oncology as my fellowship. This was because of several people with cancer I met during medical school who really affected me. People with cancer are living through a challenging time with very high stakes, which can be very costly to them and their families on an emotional, physical, and financial level.

But why I chose to spend the rest of my life taking care of people with cancer is honestly hope. A decade ago in Lebanon, you could not have looked in the face of a young person with acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), lung cancer, pancreatic cancer, or multiple myeloma and tell them there was hope. Now, you can tell them with absolute confidence there is hope. This is all because of the amazing science, development, and groundbreaking discoveries that have happened recently in this field.

What is particularly close to my heart is the relationship I get to build with my patients. People with cancer can spend months in and out of the hospital, and I end up becoming friends with them. In cancer care, you see people who, despite suffering, often continue to display the highest level of courage and morale. This is what made and still makes me fall in love with this specialty every day.

What cancer is like in Lebanon

Demographics in Lebanon are a little different than in other countries. This is because Lebanon has 2 communities: the Lebanese community, which constitutes around 4 million people, and the refugee community, which constitutes around 2 million people. The overall number of new cancer cases in Lebanon is 11,589, with 6,438 cancer deaths distributed over both communities, according to the International Agency for Research on Cancer. However, the prevalence of cancer, access to treatment, and treatment outcomes vary significantly between the Lebanese community and the refugee community due to multiple demographic factors.

Fortunately, we have a lot of well-trained oncologists in Lebanon, and the field is still growing. However, not all people have equal access to health care because there are few specialized cancer centers, and most of those centers are in the capital city of Beirut.

How Lebanese people with cancer access care

In Lebanon, all Lebanese patients have access to medication through multiple pathways, including social security, medical insurance, or the Ministry of Public Health. Most medications are provided for free or for a rather small financial charge, but getting approved for a medication involves a long process of paperwork to receive approval, and some medications may not be covered.

It should also be noted that the degree of financial coverage is not the same for all medications, procedures, and imaging tests, as the cost varies between the different insurances. It used to be otherwise, but unfortunately, after the August 2020 Beirut explosion and with the current economic crisis in which Lebanon has the second highest inflation rate in the world and our currency losing most of its value, a lot of medications are missing from the market. This has led oncologists needing to change treatment regimens to use available alternatives. Some medications, however, cannot be found or have no available alternatives, so people with cancer and their families try to get the medication from abroad through relatives or even by traveling themselves.

How cancer care differs for refugees in Lebanon

For refugees in Lebanon, cancer care is disastrous. Refugees are not covered by the Ministry of Public Health, so they depend mainly on non-governmental organizations, the United Nations, and the United Nations Relief and Works Agency (UNRWA) for aid in order to get access to cancer diagnosis and treatment.

However, most of these organizations do not cover the full cost of treatment, which puts the burden of the financial cost on the person with cancer and their family. For those unable to afford it, it leaves the families with great sorrow and guilt. If you pass through the refugee camps, you hear a lot of sad stories of people with cancer who started treatment but were not able to finish all the cycles because of the costs of care. Because of that, unfortunately, treatment for the cancer is often unsuccessful.

This really sheds light on the importance of cancer care among refugees and in conflict areas, even in the middle of war and displacement. Refugees are human beings who did not choose to be in the situation they are, and they deserve equal access to treatment. It is my goal to help work on this problem, being someone who came from this background and who has witnessed firsthand its devastating effects.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...